Atlas Trials

Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer

Clinical trial NCT06358625 · RECRUITING

Trial details

NCT number
NCT06358625
Sponsor
Center Eugene Marquis
Status
RECRUITING
Study type
OBSERVATIONAL
HER2-positive Breast Cancer
Start date
2024-06-06
Primary completion
2031-06-06
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.